THE PSCI PRESENTS ITS ANNUAL PUBLIC AUDIT FINDINGS REPORT, PROVIDING CONTINUED INSIGHTS AND REVIEW OF SUPPLIER PRACTICES, REFLECTING THE COMMITMENT OF THE PSCI AND ITS MEMBERS TO A RESPONSIBLE, RESILIENT PHARMACEUTICAL AND HEALTHCARE SUPPLY CHAIN.

Each year, the PSCI analyzes the audit findings to identify trends, highlight improvements, and share recommendations. Overall, this analysis provides deep insight into supplier practices within the pharmaceutical and healthcare industry.

In 2025, Members and suppliers uploaded a record number of over 240 audits to the PSCI platform, reflecting a significant collective effort. These audits generated more than 2,500 findings identified by auditors across the five PSCI Principles: Governance & Management Systems, Ethics, Human Rights, Environment, and Health & Safety. The analysis presented in this report offers a snapshot of suppliers’ real-world practices, highlighting recurring challenges and identifying areas where joint action can deliver the greatest impact.

The report is structured in three parts:

1. A deep dive exploring the most common findings within each Principle, supported by qualitative examples from auditor observations.
2. A regional analysis looking at patterns in China, India, the United States, Western Europe, and other regions.
3. An insights section further interpreting findings from the perspectives of supplier categories, audit topic coverage, and onsite vs remote audits.

The Audit Findings Analysis report demonstrates the PSCI Members’ shared goal to translate audit evidence into actionable insights. These insights prioritize the PSCI’s provision of supplier training topics, practical guidance, and collaboration with regional partners, ultimately supporting safer work, stronger rights, reduced environmental impact, and responsible business conduct across global supply chains.

For more details, access the full report in the resource attached.